Suivant

Lecture automatique

Acute Lymphoblastic Leukemia: Challenges in MRD Testing

2 Vues • 08/04/23
Partager
Intégrer
administrator
administrator
Les abonnés
0

Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.

Montre plus
0 commentaires sort Trier par
Commentaires de Facebook

Suivant

Lecture automatique